Form 4: Integer Holdings Director Receives 1,967 Stock Units

Director Martin C. Maxwell was granted 1,967 restricted stock units, bringing his total ownership in Integer Holdings to 25,106 shares.

Summary

• Director Martin C. Maxwell received a grant of 1,967 restricted stock units (RSUs) on May 20, 2026.
• The RSUs are scheduled to vest in four equal installments between August 2026 and May 2027.
• Each RSU converts into one share of common stock upon vesting on a one-for-one basis.
• Following this transaction, the director's total beneficial ownership increased to 25,106 shares.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a routine and positive governance event that maintains insider alignment without creating significant dilution.

Positives

• Strengthens the alignment between board members and shareholders through equity-based compensation.
• Demonstrates a significant long-term commitment by a key director with over 25,000 shares held.
• Structured vesting schedule ensures continued oversight and retention of board expertise.

Negatives

• No negative financial or operational impacts are associated with this routine compensation grant.

Risks

• The realized value of the grant is dependent on the future market performance of Integer Holdings stock.
• Vesting is contingent upon the director's continued service on the board through May 2027.

Future Outlook

The grant of 1,967 RSUs will vest in four installments through May 18, 2027, ensuring the director's continued alignment with the company's strategic objectives over the coming year.

Industry Context

StockSavvy.ai notes that Integer Holdings Corp's use of restricted stock units for director compensation is standard practice among mid-cap medical technology firms to ensure board stability and focus on long-term shareholder value.

Comparison to Industry Standards

• The grant size of 1,967 units is consistent with annual equity awards for directors at peer companies such as Merit Medical Systems.
• The quarterly vesting structure aligns with best practices for corporate governance in the S&P 400 index.

Stakeholder Impact

• Shareholders benefit from having a board of directors with a direct financial interest in the company's stock performance.

Next Steps

• Vesting of first installment on August 20, 2026.
• Vesting of second installment on November 20, 2026.
• Vesting of third installment on February 20, 2027.
• Vesting of final installment on May 18, 2027.

Key Dates

Recommendation

This administrative update regarding director compensation does not indicate a change in the company's fundamental outlook or financial health, making a hold recommendation appropriate for most investors.

Keywords

Integer Holdings, ITGR, Insider Trading, Form 4, Restricted Stock Units, Director Compensation, Medical Device Manufacturing